Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Generation Bio (GBIO) Earnings Date, Estimates & Call Transcripts

Generation Bio logo

Generation Bio Earnings Summary

Generation Bio released Q3 2025 earnings on November 5, 2025, reporting an EPS of -$0.82, which beat the consensus estimate of -$3.18 by $2.36. Quarterly revenue was reported to be $1.59 million, above analysts' expectations of $0.66 million. With a trailing EPS of -$9.34, Generation Bio's earnings are expected to grow next year, from ($1.75) to ($0.95) per share.

Latest Q3
Earnings Date
Nov. 5Estimated
Consensus EPS
(Nov. 5)
-$3.18
Actual EPS
(Nov. 5)
-$0.82 Beat By $2.36
Actual Revenue
(Nov. 5)
$1.59M

Q3 2025 Earnings Resources

Get Generation Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Generation Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

GBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Generation Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.47-$0.47-$0.47
Q2 20261-$0.36-$0.36-$0.36
Q3 20261-$0.33-$0.33-$0.33
Q4 20261-$0.33-$0.33-$0.33

Generation Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2025Q3 2025-$3.18-$0.82+$2.36-$0.82$0.66M$1.59M
8/12/2025Q2 2025-$2.80-$3.12 -$0.32-$3.12$2.51M$0.77M
5/7/2025Q1 2025-$2.50-$2.20+$0.30-$0.22$1.70M$8.72M
3/19/2025Q4 2024-$3.10-$3.20 -$0.10-$0.32$2.92M$4.19M
8/7/2024Q2 2024-$2.70-$3.10 -$0.40-$0.31$3.23M$4.09M
5/13/2024Q1 2024-$3.60-$11.20 -$7.60-$1.12$3.02M$4.06M

Data powered by Fiscal.ai.

Generation Bio Earnings - Frequently Asked Questions

Generation Bio (NASDAQ:GBIO) last announced its quarterly earning data on Wednesday, November 5, 2025. Learn more on GBIO's earnings history.

In the previous quarter, Generation Bio (NASDAQ:GBIO) reported ($0.82) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.18) by $2.36. Learn more on analysts' earnings estimate vs. GBIO's actual earnings.

Generation Bio (NASDAQ:GBIO) has a recorded annual revenue of $19.89 million.

Generation Bio (NASDAQ:GBIO) has a recorded net income of -$131.67 million. GBIO has generated -$9.34 earnings per share over the last four quarters.

Generation Bio's earnings are expected to grow from ($1.75) per share to ($0.95) per share in the next year.


This page (NASDAQ:GBIO) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners